Corbenic Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-156
Closed -$10K 264
2021
Q4
$10K Hold
156
﹤0.01% 171
2021
Q3
$10K Hold
156
﹤0.01% 167
2021
Q2
$9K Hold
156
﹤0.01% 185
2021
Q1
$9K Hold
156
﹤0.01% 179
2020
Q4
$7K Hold
156
﹤0.01% 140
2020
Q3
$6K Hold
156
﹤0.01% 122
2020
Q2
$6K Hold
156
﹤0.01% 116
2020
Q1
$5K Hold
156
﹤0.01% 122
2019
Q4
$8K Buy
+156
New +$7.53K 0.01% 129
2017
Q4
$18K Buy
356
+156
+78% +$8.22K 0.02% 108
2017
Q3
$10K Buy
+200
New +$9.74K 0.01% 150

Other funds holding MET

Corbenic Partners's MET Position: Q1 2022 in Review

Corbenic Partners sold out of MetLife (MET) in Q1 2022, closing a stake of 156 shares — an estimated $10K sold.

Corbenic Partners first reported a position in MET in Q3 2017 and held it in 11 quarters. The position peaked at $18K in Q4 2017. 1,223 funds tracked by Wall St. Rank hold MET as of Q1 2022.

  • Corbenic Partners reported no remaining MetLife position as of Q1 2022 after selling out during the quarter.
  • Corbenic Partners sold 156 MetLife shares in Q1 2022, an estimated $10K.
  • Corbenic Partners first reported a position in MetLife in Q3 2017 and held it in 11 quarters.
  • Corbenic Partners's MetLife position peaked at $18K in Q4 2017.
  • 1,223 funds tracked by Wall St. Rank held MetLife as of Q1 2022.

Based on Corbenic Partners's 13F filing for Q1 2022, filed 14 Apr 2022.